Achieve Life Sciences, Inc.

NASDAQ:ACHV

Biotechnology

Healthcare
$6.78 -7.00%

-$0.38 today

Market cap
$697.68M
Beta
2.26
P/E (TTM)
-5.1
EPS (TTM)
-$0.97
52W Low $2.00High $6.16

Volume 1.09M

Average 1.44M

ACHV Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

Achieve Life Sciences, Inc.NASDAQ: ACHV

Short-term Debt · Q1 FY2026 · quarter ended Mar 2026

Short-term debt rises 367.3% from a year ago

Short-term debt stood at $5.58M at the end of Q1 FY2026, up 367.3% from a year earlier and up 48.2% from the prior quarter. Over 3 fiscal years it compounded at -38.4% a year.

Context

  • Short-term debt amounted to 16.9% of total assets at the end of Q1 FY2026, up 12.5 pp from a year earlier.
  • Short-term debt increased in 2 of the last 3 fiscal years.

What to watch

Whether short-term debt keeps rising in the next quarterly balance sheet after a +367.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.58M+48.2% QoQ
Last fiscal yearDec 2025
$3.77M— YoY
Year agoMar 2025
$1.19M+367.3% since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+367.3%——
1 year———
3-year CAGR-38.4%——
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2025
3.77M USD
Year-over-year change
—

Short-term Debt vs competitors

How ACHV compares with its peers on the latest reported figures

No competitor Short-term Debt figures are available to compare.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents43.02M24.72M15.55M12.73M20.93M
Short-term Investments00021.61M15.48M
Net Receivables153K105K111K00
Inventory00000
Other Current Assets02.5M1.33M2.13M3.49M
Total Current Assets44.59M27.33M16.98M36.47M39.89M
Property, Plant & Equipment (Net)64K123K79K119K64K
Goodwill1.03M1.03M1.03M1.03M1.03M
Intangible Assets1.64M1.42M1.2M974K751K
Long-term Investments0050K020K
Tax Assets0000283K
Other Non-current Assets183K66K29K39K(251K)
Total Non-current Assets2.92M2.64M2.39M2.17M1.9M
Total Assets47.52M29.97M19.37M38.63M41.79M
Account Payables841K1.66M618K1.95M867K
Short-term Debt016.07M16.66M03.77M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.94M1.68M2.84M3.03M2.53M
Total Current Liabilities4.55M21.6M20.81M6.68M9.08M
Long-term Debt14.92M009.84M11.19M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0001.15M0
Total Non-current Liabilities14.92M69K6K11.05M11.19M
Total Liabilities19.47M21.67M20.82M17.73M20.27M
Common Stock79K87K90K103K121K
Retained Earnings(93.59M)(135.94M)(165.75M)(205.58M)(260.23M)
Accumulated OCI4K4K4K31K10K
Other Stockholders Equity00000
Minority Interest00000
Total Equity28.04M8.3M(1.45M)20.9M21.52M
Total Debt14.99M16.2M16.73M9.96M14.96M
Net Debt(28.03M)(8.52M)1.19M(2.78M)(5.97M)

Achieve Life Sciences, Inc.

NASDAQ:ACHV

Intrinsic Alpha fair value

Locked

Current Price

$6.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.